|
Yayın Bilgisi |
Atıf Sayısı |
Adres |
1 |
Erdogar, N; Mungan, A; Bilensoy, E, “Preparation and characterization of cationic nanoparticles loaded with mitomycin c by double emulsion and ionotropic gelation techniques”, J CONTR REL, Sayfa 0-0, 2010 |
2 |
|
2 |
Cirpanli, Y; Bilensoy, E; Dogan, AL; Calis, S, “Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery”, J CONTR REL, Sayfa 0-0, 2010 |
5 |
|
3 |
Hincal, AA; Eroglu, H; Bilensoy, E, “Safety and Efficacy of Amphiphilic Cyclodextrins for Drug Delivery”, DRUG METAB, Sayfa 12-13, 2010 |
0 |
|
4 |
Sarisozen, C; Aktas, Y; Mungan, A; Bilensoy, E, “Bioadhesive coated poly-epsilon-caprolactone nanoparticles loaded with Mitomycin C for the treatment of superficial bladder tumors”, EUR J PH SC, Sayfa 0-0, 2007 |
1 |
|
5 |
Rouf, MA; Bilensoy, E; Vural, I; Hincal, AA, “Determination of stability of rapamycin following exposure to different conditions”, EUR J PH SC, Sayfa 0-0, 2007 |
6 |
|
6 |
Rouf, MA; Bilensoy, E; Vural, I; Hincal, AA, “Inclusion complexation of rapamycin with beta-cyclodextrin to improve solubility and stability of the drug”, EUR J PH SC, Sayfa 0-0, 2007 |
4 |
|
7 |
Cirpanli, Y; Bilensoy, E; Calis, S; Hincal, AA, “Stabilization of camptothecin in PLGA nanoparticles”, EUR J PH SC, Sayfa 0-0, 2007 |
0 |
|
8 |
Bilensoy, E, “Tumor targeted nanoparticles for cancer therapy”, EUR J PH SC, Sayfa 0-0, 2007 |
1 |
|
9 |
Hincal, AA; Bilensoy, E, “Formulation of poorly water soluble drugs with amphiphilic beta cyclodextrins”, EUR J PH SC, Sayfa 0-0, 2006 |
0 |
|
10 |
Bilensoy, E, “Targeted nanoparticles for cancer therapy”, FEBS J, Sayfa 35-35, 2006 |
0 |
|
11 |
Bilensoy, E; Rouf, MA; Vural, I; Hincal, AA, “Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin”, J CONTR REL, Sayfa 0-0, 2006 |
7 |
|
12 |
Memisoglu-Bilensoy, E, “Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: system development and evaluation”, EUR J PH SC, Sayfa 0-0, 2005 |
1 |
|